Form 4: Teladoc Health Director David Shedlarz Converts RSUs and Receives New Equity Grant

Teladoc Health, Inc. Director David L. Shedlarz reported the conversion of previously granted restricted stock units into common stock and the acquisition of new restricted stock units.

Summary

• On May 21, 2025, Teladoc Health Director David L. Shedlarz converted 17,467 restricted stock units (RSUs) into an equal number of common shares of Teladoc Health, Inc. (TDOC).
• These 17,467 RSUs were originally granted on May 23, 2024, and vested in full on May 21, 2025.
• Following this conversion, Mr. Shedlarz beneficially owns 32,280 shares of Teladoc Health common stock.
• On May 22, 2025, Mr. Shedlarz was granted an additional 28,986 restricted stock units.
• These new 28,986 RSUs represent a contingent right to receive one share of TDOC common stock per unit and will vest in full on the earlier of May 22, 2026, or the day immediately preceding the issuer's 2026 annual meeting of stockholders.
• After these transactions, Mr. Shedlarz beneficially owns 28,986 derivative securities (RSUs).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive as it reflects routine compensation and continued alignment of a director's interests with the company through equity grants, without indicating any unusual or negative events.

Positives

• The acquisition of new restricted stock units by a director indicates continued alignment of management interests with shareholder value.
• The vesting and conversion of previously granted RSUs demonstrate the execution of a pre-planned compensation structure.

Future Outlook

The newly granted restricted stock units are scheduled to vest by May 22, 2026, or earlier, aligning the director's future compensation with the company's performance over the next year.

Industry Context

This Form 4 filing is a routine disclosure of insider equity transactions, common across all publicly traded companies, and does not provide specific insights into broader industry trends within the telehealth or healthcare sectors.

Stakeholder Impact

• Shareholders: This filing indicates a director's ongoing equity ownership and participation in the company's compensation structure, aligning their interests with shareholder value. It is a routine disclosure and does not suggest significant immediate impact on share price.

Next Steps

• The 28,986 restricted stock units granted on May 22, 2025, are expected to vest on the earlier of May 22, 2026, or the day immediately preceding Teladoc Health's 2026 annual meeting of stockholders.

Key Dates

Keywords

Teladoc Health, TDOC, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Beneficial Ownership